Annotation Detail

Information
Associated Genes
IDH1
Associated Variants
IDH1 MUTATION
IDH1 MUTATION
Associated Disease
brain glioma
Source Database
CIViC Evidence
Description
Genomewide analysis of 250 low-grade adult gliomas revealed that patients with a wildtype IDH1/2 had significantly shorter overall survival than those with a mutated IDH gene (HR 7.4; 95%CI: 4.0-13.8). The median survival for patients with low grade gliomas was 1.7 years for patients with wild-type IDH (N=55); 6.3 years for patients with mutated IDH and no 1p/19q co-deletion (N=139); and 8.0 years for patients with IDH mutation and a 1p/19q co-deletion (N=84).
Variant Origin
somatic
Variant Origin
Somatic
Evidence URL
https://civic.genome.wustl.edu/links/evidence_items/1639
Gene URL
https://civic.genome.wustl.edu/links/genes/26
Variant URL
https://civic.genome.wustl.edu/links/variants/645
Rating
3
Evidence Type
Prognostic
Disease
Brain Glioma
Evidence Direction
Supports
Evidence Level
B
Clinical Significance
Better Outcome
Pubmed
26061751
Drugs